ConductScience.org, home

Paper10754451

Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes.

DeLeve LD and 1 other. Pharmacology, 2000. Cited by 97 papers, by iCite.

Cite this record

ConductScience Library. Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes. Papers, record 10754451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10754451

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes.
PubMed
Journal
Pharmacology
PubMed
Year
2000
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
97
iCite
Relative citation ratio, by iCite
2.74
iCite
Revised in PubMed
2017-11-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1DeLeve LDL D
2Wang XX

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alkylating AgentsMajor topic
BusulfanMajor topic
GlutathioneMajor topic
LiverMajor topic
Oxidative StressMajor topic
Animals
Cells, Cultured
Male
Mice
Mice, Inbred C3H
Thiobarbituric Acid Reactive Substances

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
DK 46357NIDDK NIH HHSUnited StatesR01DK046357PubMed and NIHNIH RePORTER
R29DK046357NIHNIH RePORTER

Download CSV of grants

Cited by49

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 97 citations.

PMIDTitleJournalYearIn PapersSource
41896325Risk factors for alloimmune lung syndromes after allogeneic hematopoietic cell transplantation in children.Bone Marrow Transplant2026https://conductscience.org/library/papers/41896325PubMed
41730941Busulfan resistance in AML is associated with changes in mitochondrial copy number and lipid metabolism.Sci Rep2026https://conductscience.org/library/papers/41730941PubMed
39408056Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma.J Clin Med2024https://conductscience.org/library/papers/39408056PubMed
38966316Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics.Adv Pharmacol Pharm Sci2024https://conductscience.org/library/papers/38966316PubMed
38936939In Vivo Cytotoxic, Genotoxic and Radiosensitizing Effects of Clofarabine.In Vivo2024https://conductscience.org/library/papers/38936939PubMed
38458191Restoration of fertility in nonablated recipient mice after spermatogonial stem cell transplantation.Stem Cell Reports2024https://conductscience.org/library/papers/38458191PubMed
38276491Population Pharmacokinetic Modeling for Twice-Daily Intravenous Busulfan in a Large Cohort of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation-A 10-Year Single-Center Experience.Pharmaceutics2023https://conductscience.org/library/papers/38276491PubMed
37899250WIN18,446 enhances spermatogonial stem cell homing and fertility after germ cell transplantation by increasing blood-testis barrier permeability.J Reprod Dev2023https://conductscience.org/library/papers/37899250PubMed
37086290Hypofibrinolysis in pediatric patients with veno-occlusive disease in hematopoietic stem cell transplantation.J Cancer Res Clin Oncol2023https://conductscience.org/library/papers/37086290PubMed
37085674Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan.Bone Marrow Transplant2023https://conductscience.org/library/papers/37085674PubMed
36834506Alginate Oligosaccharides Repair Liver Injury by Improving Anti-Inflammatory Capacity in a Busulfan-Induced Mouse Model.Int J Mol Sci2023https://conductscience.org/library/papers/36834506PubMed
35611997Population pharmacokinetic model for once-daily intravenous busulfan in pediatric subjects describing time-associated clearance.CPT Pharmacometrics Syst Pharmacol2022https://conductscience.org/library/papers/35611997PubMed
35361896Impact of busulfan pharmacokinetics on outcome in adult patients receiving an allogeneic hematopoietic cell transplantation.Bone Marrow Transplant2022https://conductscience.org/library/papers/35361896PubMed
34499222
GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation.
J Cancer Res Clin Oncol2022https://conductscience.org/library/papers/34499222PubMed
33384597
NRF2 -617 C/A Polymorphism Impacts Proinflammatory Cytokine Levels, Survival, and Transplant-Related Mortality After Hematopoietic Stem Cell Transplantation in Adult Patients Receiving Busulfan-Based Conditioning Regimens.
Front Pharmacol2020https://conductscience.org/library/papers/33384597PubMed
33128207Review of the Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Paediatric Patients.Clin Pharmacokinet2021https://conductscience.org/library/papers/33128207PubMed
33098041Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial.Ann Hematol2021https://conductscience.org/library/papers/33098041PubMed
33064008Prediction of Acute Graft versus Host Disease and Relapse by Endogenous Metabolomic Compounds in Patients Receiving Personalized Busulfan-Based Conditioning.J Proteome Res2021https://conductscience.org/library/papers/33064008PubMed
33024523Evaluation of Reversed Administration Order of Busulfan (BU) and Cyclophosphamide (CY) as Conditioning on Liver Toxicity in Allogenic Hematopoietic Stem Cell Transplantation (ALL-HSCT).Int J Hematol Oncol Stem Cell Res2020https://conductscience.org/library/papers/33024523PubMed
32318059Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation.Front Immunol2020https://conductscience.org/library/papers/32318059PubMed

See all 49 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10754451

GET https://conductscience.org/api/papers/v1/10754451/cited_by?page=2